Navigation Links
Drug May Delay Nursing Home Placement for Dementia Patients

Publishing in the September issue of Alzheimer’s Disease and Associated Disorders researchers from the University of South Florida’s Louis de la Parte Florida Mental Health// Institute’s (FMHI) Department of Mental Health, Law and Policy and the School of Aging Studies report finding that treating dementia patients with cholinesterase inhibitors (ChE-Is) may delay placement into nursing homes and provide improved quality of life while helping preserve personal and societal resources.

“Dementia is a very debilitating condition,” said co-author Ross Andel of the USF School of Aging Studies and the Florida Alzheimer’s Disease Research Center. “It affects up to 10 percent of adults over 65 and can account for up to 70 percent of the long-term care, nursing home population. This study provided evidence that treatment with ChE-Is can delay nursing home placement by an average of three and a half months, possibly as a function of temporary stabilization of cognitive and functional abilities.”

According to the Alzheimer’s Association (http://www.alz.org), ChE-Is are designed to increase levels of acetylcholine, a chemical messenger involved in memory and thought processing. The drug, first approved by the FDA in 1993, is known by several trade names, including Aricept, Exelon and Razadyne http://www.alz.org/Resources/
TopicIndex/cholinesteraseinhibitors.asp

To carry out this study, researchers used records from the Florida Medicaid program to follow separate groups of patients over age 60 with dementia who were either taking or not taking ChE-Is and had not been placed in a nursing home.

“The group of patients who were already taking ChE-Is were significantly older and included more women,” said lead author Marion Becker of FMHI. “That those taking ChE-Is were placed in a nursing home more than three months later than those not taking the drug has implications not only for patients and their families, but for controlling
'"/>




Page: 1 2

Related medicine news :

1. Smoking Delays Pregnancy
2. Delaying Parkinson’s Diseas
3. Lifestyle changes Can Delay the Onset Of Dementia
4. Lifestyle changes Can Delay the Onset Of Dementia
5. Lifestyle changes Can Delay the Onset Of Dementia
6. A Vitamin A Day May Delay The Life span Of HIV Patients
7. Delaying The Progression Of Alzheimer’s Disease
8. The Effects Of Delaying A Delivery Questioned
9. Drug to Delay the Onset of Arthritis
10. Delaying pregnancy may lessen life expectancy of the child
11. In Early Epilepsy Delay in medications Recommended
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug May Delay Nursing Home Placement for Dementia Patients

(Date:4/20/2015)... (PRWEB) April 20, 2015 Mutare ... has secured nationally-renowned Gastroenterologist Lawrence Kosinski, MD, MBA, ... , Dr. Kosinski brings a unique combination of ... to the Mutare Health team as ... communication, collaboration, and quality of care in the ...
(Date:4/20/2015)... Danbury, Connecticut (PRWEB) April 20, 2015 ... that Moreen Donahue, DNP, RN, NEA-BC, FAAN who ... for Nursing Education and Research in September 2014, ... Chief Nursing Officer to lead the development of ... In this newly created role, Donahue will be ...
(Date:4/20/2015)... April 20, 2015 Novatus, a ... further expanded its service level to the growing ... in Amsterdam and Paris. After a rigorous ... sophisticated levels of resilience, security and operational expertise, ... milestone for Novatus as we expand our footprint ...
(Date:4/20/2015)... Southfield, MI (PRWEB) April 20, 2015 ... products is a personal matter that many customers would prefer ... offering as of March 30th a discreet delivery method allowing ... have them arrive at their home without fear of a ... This discreet shipping method is available now on all orders ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 America’s ... the U.S. health insurance industry, is seeking greater ... the recent controversy involving surgical tools called power ... U.S. Senator Robert Casey (D-PA) dated April 14th, ... uterine morcellation point to “serious gaps in the ...
Breaking Medicine News(10 mins):Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 3Health News:Nursing Executive to Develop and Lead Nursing Leadership Program at Western Connecticut Health Network 2Health News:Novatus Expands into European Data Centers 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 4
... years,since the nation,s capital was stunned by terrorist ... are we any better prepared now than we,were ... Hospital,Center will answer the question, Tuesday evening, October ... READY?" -- as they present the,Washington Hospital Center,s ...
... Renowned Therapist Challenges Modern Psychology and Explodes Myths of ,Why ... ... children have a,genetic predisposition to bad behavior and are more difficult to ... parents, has,been the cross parents have had to bear for decades, placing ...
... October 29, 2007 - A new study published in ... self-reported active epilepsy and health-related quality of life among ... data collected in the 2003 California Health Interview Survey ... finds that in 2003, almost 300,000 (1.2 percent) adults ...
... - Monthly blog will appear in conjunction with ... 29 The Kellogg School,of Management at Northwestern ... monthly blog developed by David Dranove, the Kellogg ... Management.,"Code Red" is accessible at the following link:, ...
... (Amex: PRZ ), one of the nation,s leading ... announced that at its,2007 Annual Meeting of Stockholders held ... of board members and the,ratification of Brimmer, Burek & ... ending December 31, 2007. Re-elected board members, who ...
... Pharmaceuticals,Inc., which discovers and develops novel antiviral therapeutics ... of Steven D.,Skolsky as its President and Chief ... of the Board of Directors. "Sequoia is ... as Steven Skolsky," said Chris Mirabelli, Chairman of ...
Cached Medicine News:Health News:Are We Ready? Washington Hospital Center Sets Precedents in Preparedness for 9/11-Style Attacks 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 3Health News:Kellogg School of Management Announces 'Code Red' 2Health News:PainCare Announces Results of 2007 Annual Meeting of Stockholders 2Health News:PainCare Announces Results of 2007 Annual Meeting of Stockholders 3Health News:Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer 2
(Date:4/20/2015)... 20, 2015 International Isotopes Inc. (OTCQB: ... shareholders with the following update on its business ... Historically, INIS has produced and sold ... models of sealed sources for medical and industrial ... therapy, security examination, and radiography.  Due to technical ...
(Date:4/20/2015)... KANNAPOLIS, N.C. , April 20, 2015 /PRNewswire/ ... managed care organization that focuses on high-tech, high-touch ... for delivering behavioral health services during the National ... The event, which takes place April 20–22, 2015, ... in Orlando, Fla. , attracts ...
(Date:4/20/2015)... , April 20, 2015 Eli Lilly ... the investigational medicine ixekizumab was statistically superior to placebo ... (PsA), as demonstrated by the proportion of patients achieving ... assessment that represents a 20 percent reduction in disease ... of Rheumatology response criteria. During the 24-week, Phase 3 ...
Breaking Medicine Technology:International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 2International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 3International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 4International Isotopes Inc. Provides Shareholders With An Update On New Opportunities And Positive Developments Within Its Existing Business Segments 5Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 2Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 2Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 4
... LAUSANNE, Switzerland, July 21 Debiopharm Group,(Debiopharm), ... focus on the development of prescription drugs that ... agency for therapeutic products,Swissmedic, has issued a marketing ... prescribed for a reversible reduction,of serum testosterone to ...
... Ueno, Ltd. announced on July 17 that as a phase 1 ... by our company as a therapeutic drug of androgenetic alopecia (male ... , The phase 1 clinical study of ... study and 5-day repeated-dose study. Since no serious adverse event occurred ...
Cached Medicine Technology:Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations 2Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations 3R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023 2R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: